<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD006386-sec1-0001" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD006386-sec1-0001"></div> <div class="table" id="CD006386-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings for the main comparison.</span>Â <span class="table-title">Induction chemotherapy plus Locoregional treatment (LRT) versus LRT alone for the treatment of oral cavity and oropharyngeal cancer</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Induction chemotherapy plus Locoregional treatment (LRT) versus LRT alone for the treatment of oral cavity and oropharyngeal cancer</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients with oral cavity and oropharyngeal cancer <br><b>Settings:</b> hospital <br><b>Intervention:</b> induction chemotherapy plus locoregional treatment (LRT) <br><b>Comparison:</b> locoregional treatment </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect <br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No of Participants <br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence <br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>locoregional treatment</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>induction chemotherapy plus locoregional treatment (LRT)</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p><b>Total Mortality</b> <br> Hazard Ratio <br> Followâup: 3â8 years </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low risk population<sup>1</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p><b>HR 0.92</b> <br> (0.84 to 1)<sup>2</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>4051 <br> (25 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>ââââ <br><b>very low</b><sup>3,4</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"></td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>200 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>186 per 1000</b> <br> (171 to 200) </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Medium risk population<sup>1</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>500 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>471 per 1000</b> <br> (441 to 500) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High risk population<sup>1</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>700 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>670 per 1000</b> <br> (636 to 700) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p><b>Total Mortality</b> <br> Followâup: 3â8 years </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low risk population<sup>1</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p><b>HR 0.80</b> <br> (0.67 to 0.97)<sup>5</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>968 <br> (4 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>ââââ <br><b>moderate</b><sup>4</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>200 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>163 per 1000</b> <br> (139 to 195) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Medium risk population<sup>1</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>500 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>426 per 1000</b> <br> (371 to 489) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High risk population<sup>1</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>700 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>618 per 1000</b> <br> (554 to 689) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br><b>CI:</b> Confidence interval; <b>HR:</b> Hazard ratio; </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence <br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Control risk based on 5 year mortality data in McGurk 2005 <br><sup>2</sup> Analysis conducted on all included studies <br><sup>3</sup> Four studies at low risk of bias, 12 are unclear and 9 are at high risk of bias <br><sup>4</sup> Studies included patients with other head and neck cancers <br><sup>5</sup> Analysis conducted on included studies at low risk of bias </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006386-tbl-0002"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 2.</span>Â <span class="table-title">Surgery +/â RT + chemotherapy compared to surgery +/â RT alone for oral cavity and oropharyngeal cancer</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Surgery +/â RT + chemotherapy compared to surgery +/â RT alone for oral cavity and oropharyngeal cancer</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients with oral cavity and oropharyngeal cancer <br><b>Settings:</b> hospital <br><b>Intervention:</b> surgery +/â RT + chemotherapy <br><b>Comparison:</b> surgery +/â RT alone </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect <br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No of Participants <br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence <br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>surgery +/â RT alone</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>surgery +/â RT + chemotherapy</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p><b>Total Mortality</b> <br> Hazard Ratio <br> Followâup: 3â8 years </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low risk population<sup>1</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p><b>HR 0.88</b> <br> (0.79 to 0.99) </p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>2017 <br> (10 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>ââââ <br><b>low</b><sup>2,3</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"></td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>200 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>178 per 1000</b> <br> (162 to 198) </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Medium risk population<sup>1</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>500 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>457 per 1000</b> <br> (422 to 497) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High risk population<sup>1</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>700 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>653 per 1000</b> <br> (614 to 696) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p><b>Total Mortality</b> <br> Followâup: 3â8 years </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low risk population<sup>1</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p><b>HR 0.88</b> <br> (0.74 to 1.05)<sup>4</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>758 <br> (4 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>ââââ <br><b>moderate</b><sup>3</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>200 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>178 per 1000</b> <br> (152 to 209) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Medium risk population<sup>1</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>500 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>457 per 1000</b> <br> (401 to 517) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High risk population<sup>1</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>700 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>653 per 1000</b> <br> (590 to 718) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br><b>CI:</b> Confidence interval; <b>HR:</b> Hazard ratio; </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence <br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Based on 5âyear mortality data in McGurk 2005 <br><sup>2</sup> Four studies are at low risk of bias and 6 are at unclear risk of bias <br><sup>3</sup> Studies included patients with other head and neck cancers <br><sup>4</sup> Analysis conducted on included studies at low risk of bias </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006386-tbl-0003"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 3.</span>Â <span class="table-title">Concomitant chemoradiotherapy compared to radiotherapy alone for oral cavity and oropharyngeal cancer</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Concomitant chemoradiotherapy compared to radiotherapy alone for oral cavity and oropharyngeal cancer</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients with oral cavity and oropharyngeal cancer <br><b>Settings:</b> hospital <br><b>Intervention:</b> concomitant chemoradiotherapy <br><b>Comparison:</b> radiotherapy alone </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect <br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No of Participants <br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence <br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>radiotherapy alone</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>concomitant chemoradiotherapy</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p><b>Total Mortality</b> <br> Hazard Ratio <br> Followâup: 3â8 years </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low risk population<sup>1</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p><b>HR 0.78</b> <br> (0.73 to 0.83)<sup>2</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>4734 <br> (26 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>ââââ <br><b>low</b><sup>3,4</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"></td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>200 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>160 per 1000</b> <br> (150 to 169) </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Medium risk population<sup>1</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>500 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>418 per 1000</b> <br> (397 to 437) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High risk population<sup>1</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>700 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>609 per 1000</b> <br> (585 to 632) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p><b>Total Mortality</b> <br> Hazard Ratio <br> Followâup: 3â8 years </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low risk population<sup>1</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p><b>HR 0.87</b> <br> (0.79 to 0.95)<sup>5</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>2266 <br> (9 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>ââââ <br><b>moderate</b><sup>4</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>200 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>176 per 1000</b> <br> (162 to 191) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Medium risk population<sup>1</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>500 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>453 per 1000</b> <br> (422 to 482) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High risk population<sup>1</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>700 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>649 per 1000</b> <br> (614 to 681) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br><b>CI:</b> Confidence interval; <b>HR:</b> Hazard ratio; </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence <br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Based on 5âyear mortality data in McGurk 2005 <br><sup>2</sup> Analysis based on all included studies <br><sup>3</sup> Nine trials are at low risk of bias, and remaining 17 at unclear risk of bias <br><sup>4</sup> Trials include patients with other head and neck cancers <br><sup>5</sup> Analysis based on included studies at low risk of bias </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
